Podcast
We spoke with Agnieszka Sekula and Prash Puspanathan, MD, co-founders of Enosis Therapeutics, about the use of virtual reality in psychedelic-assisted therapy.
In the latest episode, we spoke with Agnieszka Sekula and Prash Puspanathan, MD, co-founders of Enosis Therapeutics, about the use of virtual reality in psychedelic-assisted therapy. In addition to allowing for a range of patient-constructed settings for therapy, they said the use of virtual reality could help mitigate existing barriers within current psychedelic protocols.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.